Cardiology

Filter

New Research into Oral Semaglutide and Heart Failure Outcomes

February 2026

The secondary SOUL trial analysis shows oral semaglutide reduces heart failure events in patients with diabetes and pre-existing heart failure.

The Road to a Healthy Heart – Part 2

Greg Marcus discusses the role of ethnicity in cardiology, digital health, gadgets that support patients, and AI.

Links Between Early Education and Adult Cardiovascular Health

Researchers reported that education is the leading social determinant of health, and recommend that paediatricians and other healthcare workers should pay attention to education in young patients.

Deep Learning Model May Accurately Predict Atrial Fibrillation

According to research, AI appears to be able to predict atrial fibrillation within 1 month amongst patients with sinus rhythm. The algorithm used in this study was one of few developed to identify hidden AF in normal ECGs in diverse patients.

The Road to a Healthy Heart – Part 1

Greg Marcus joins Jonathan to explore electrophysiology, how substances affect cardiac arrythmias, and the Health eHeart study.

Live Webinar: Coronary Microvascular Dysfunction and Its Hidden Role in Persistent Angina

Two draw upon their expertise to increase awareness for the importance of interrogating microvascular function.

Identifying Optimal Treatment in Patients with Complex ASCVD

This episode navigates atherosclerotic cardiovascular disease, including plaque morphology, residual risk, secondary treatment options, and guidelines from the National Institute for Health and Care Excellence.

Research Reveals Link Between Vitamin D Deficiency and Elevated Atrial Fibrillation Risk

Vitamin D levels have been linked with an increased risk for atrial fibrillation, according to Xiaoli Ding, Gannan Medical University, China, and colleagues. This analysis incorporated data from five prospective cohorts. Read more.

Cardiac Function Remains Unaltered with Troponin-Guided Approach During Chemotherapy

The results of the Cardiac CARE trial reveal that troponin-guided carvedilol and candesartan intervention did not show any discernible impact on preserving cardiac function in patients undergoing chemotherapy.

Loading posts...

« Previous 1 … 37 38 39 40 41 … 96 Next »